Cancer Research AACR Membership  Protein Translation and Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Research 67, 11064, November 15, 2007. doi: 10.1158/0008-5472.CAN-07-2443
© 2007 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hsu, Y.-M.
Right arrow Articles by Shen, M.-R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hsu, Y.-M.
Right arrow Articles by Shen, M.-R.

Endocrinology

KCl Cotransporter-3 Down-regulates E-Cadherin/ß-Catenin Complex to Promote Epithelial-Mesenchymal Transition

Yueh-Mei Hsu1,2, Yih-Fung Chen1,2, Cheng-Yang Chou3, Ming-Jer Tang4, Ji Hshiung Chen6, Robert J. Wilkins7, J. Clive Ellory7 and Meng-Ru Shen2,3,5

1 Institute of Basic Medical Sciences, and Departments of 2 Pharmacology, 3 Obstetrics and Gynecology, and 4 Physiology, College of Medicine and 5 Center for Gene Regulation and Signal Transduction Research, National Cheng Kung University, Tainan, Taiwan; 6 Graduate Institute of Molecular and Cell Biology, College of Life Sciences, Tzu Chi University, Hualien, Taiwan; and 7 Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, United Kingdom

Requests for reprints: Meng-Ru Shen, Department of Obstetrics and Gynecology, College of Medicine, National Cheng Kung University, 138 Sheng-Li Road, Tainan 704, Taiwan. Phone: 886-6-2353535, ext. 5505; Fax: 886-6-2766185; E-mail: mrshen{at}mail.ncku.edu.tw.

The potassium chloride cotransporter (KCC) is a major determinant of osmotic homeostasis and plays an emerging role in tumor biology. Here, we investigate if KCC is involved in the regulation of epithelial-mesenchymal transition (EMT), a critical cellular event of malignancy. E-cadherin and ß-catenin colocalize in the cell-cell junctions, which becomes more obvious in a time-dependent manner by blockade of KCC activity in cervical cancer SiHa and CaSki cells. Real-time reverse transcription-PCR on the samples collected from the laser microdissection indicates that KCC3 is the most abundant KCC isoform in cervical carcinoma. The characteristics of EMT appear in KCC3-overexpressed, but not in KCC1- or KCC4-overexpressed cervical cancer cells, including the elongated cell shape, increased scattering, down-regulated epithelial markers (E-cadherin and ß-catenin), and up-regulated mesenchymal marker (vimentin). Some cellular functions are enhanced by KCC3 overexpression, such as increased invasiveness and proliferation, and weakened cell-cell association. KCC3 overexpression decreases mRNA level of E-cadherin. The promoter activity assays of various regulatory sequences confirm that KCC3 expression is a potent negative regulator for human E-cadherin gene expression. The proteosome inhibitor restores the decreased protein abundance of ß-catenin by KCC3 overexpression. In the surgical specimens of cervical carcinoma, the decreased E-cadherin amount was accompanied by the increased KCC3 abundance. Vimentin begins to appear at the invasive front and becomes significantly expressed in the tumor nest. In conclusion, KCC3 down-regulates E-cadherin/ß-catenin complex formation by inhibiting transcription of E-cadherin gene and accelerating proteosome-dependent degradation of ß-catenin protein. The disruption of E-cadherin/ß-catenin complex formation promotes EMT, thereby stimulating tumor progression. [Cancer Res 2007;67(22):11064–73]




This article has been cited by other articles:


Home page
Cancer Res.Home page
Y.-F. Chen, C.-Y. Chou, R. J. Wilkins, J. C. Ellory, D. B. Mount, and M.-R. Shen
Motor Protein-Dependent Membrane Trafficking of KCl Cotransporter-4 Is Important for Cancer Cell Invasion
Cancer Res., November 15, 2009; 69(22): 8585 - 8593.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M.-Y. Lee, C.-Y. Chou, M.-J. Tang, and M.-R. Shen
Epithelial-Mesenchymal Transition in Cervical Cancer: Correlation with Tumor Progression, Epidermal Growth Factor Receptor Overexpression, and Snail Up-Regulation
Clin. Cancer Res., August 1, 2008; 14(15): 4743 - 4750.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2007 by the American Association for Cancer Research.